Vivo Capital Surplus Fund VIII, L.P. is 10% Owner at IMPEL PHARMACEUTICALS INC (IMPL). They have made 6 open-market trades across 5 companies since 2020, most recently 2023-12-19.
CIK 0001628048
3 open-market purchases totalling $20.2M since 2020, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMPL | SELL | 2023-12-15 | 2023-12-19 | $0.13 | $74K | N/A | N/A | N/A |
| BOLT | SELL | 2023-11-16 | 2023-11-20 | $0.93 | $80K | -5.3% | +7.4% | +22.3% |
| TERN | BUY | 2022-08-12 | 2022-08-16 | $2.98 | $3.4M | -10.2% | +27.9% | -8.0% |
| IMPL | BUY | 2021-04-27 | 2021-04-29 | $15.00 | $8.6M | -3.6% | -34.4% | -16.5% |
| ALGS | BUY | 2020-10-20 | 2020-10-20 | $15.00 | $8.3M | +11.3% | +48.3% | +132.0% |
| CRNX | SELL | 2020-04-15 | 2020-04-17 | $15.45 | $10.1M | +10.3% | +29.7% | -5.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.